Literature DB >> 12093316

Food-drug interactions.

Lars E Schmidt1, Kim Dalhoff.   

Abstract

Interactions between food and drugs may inadvertently reduce or increase the drug effect. The majority of clinically relevant food-drug interactions are caused by food-induced changes in the bioavailability of the drug. Since the bioavailability and clinical effect of most drugs are correlated, the bioavailability is an important pharmacokinetic effect parameter. However, in order to evaluate the clinical relevance of a food-drug interaction, the impact of food intake on the clinical effect of the drug has to be quantified as well. As a result of quality review in healthcare systems, healthcare providers are increasingly required to develop methods for identifying and preventing adverse food-drug interactions. In this review of original literature, we have tried to provide both pharmacokinetic and clinical effect parameters of clinically relevant food-drug interactions. The most important interactions are those associated with a high risk of treatment failure arising from a significantly reduced bioavailability in the fed state. Such interactions are frequently caused by chelation with components in food (as occurs with alendronic acid, clodronic acid, didanosine, etidronic acid, penicillamine and tetracycline) or dairy products (ciprofloxacin and norfloxacin), or by other direct interactions between the drug and certain food components (avitriptan, indinavir, itraconazole solution, levodopa, melphalan, mercaptopurine and perindopril). In addition, the physiological response to food intake, in particular gastric acid secretion, may reduce the bioavailability of certain drugs (ampicillin, azithromycin capsules, didanosine, erythromycin stearate or enteric coated, and isoniazid). For other drugs, concomitant food intake may result in an increase in drug bioavailability either because of a food-induced increase in drug solubility (albendazole, atovaquone, griseofulvin, isotretinoin, lovastatin, mefloquine, saquinavir and tacrolimus) or because of the secretion of gastric acid (itraconazole capsules) or bile (griseofulvin and halofantrine) in response to food intake. For most drugs, such an increase results in a desired increase in drug effect, but in others it may result in serious toxicity (halofantrine).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093316     DOI: 10.2165/00003495-200262100-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  253 in total

1.  Interaction between fibre and lovastatin.

Authors:  W O Richter; B G Jacob; P Schwandt
Journal:  Lancet       Date:  1991-09-14       Impact factor: 79.321

2.  Interference of dairy products with the absorption of ciprofloxacin.

Authors:  P J Neuvonen; K T Kivistö; P Lehto
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

3.  Drug interactions with grapefruit: whose responsibility is it to warn the public?

Authors:  J D Spence
Journal:  Clin Pharmacol Ther       Date:  1997-04       Impact factor: 6.875

4.  Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers.

Authors:  J A Barone; J G Koh; R H Bierman; J L Colaizzi; K A Swanson; M C Gaffar; B L Moskovitz; W Mechlinski; V Van de Velde
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Interference of oral phenytoin absorption by continuous nasogastric feedings.

Authors:  L A Bauer
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

6.  Isoniazid and reaction to cheese.

Authors:  J L Lejonc; D Gusmini; P Brochard
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

7.  Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation.

Authors:  C A Knupp; R Milbrath; R H Barbhaiya
Journal:  J Clin Pharmacol       Date:  1993-06       Impact factor: 3.126

8.  Impairing effect of food on ketoconazole absorption.

Authors:  P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu; P Ottoila
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

9.  Examination of some factors responsible for a food-induced increase in absorption of atovaquone.

Authors:  P E Rolan; A J Mercer; B C Weatherley; T Holdich; H Meire; R W Peck; G Ridout; J Posner
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

10.  Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.

Authors:  C A Dujovne; M H Davidson
Journal:  Am J Med       Date:  1994-06-06       Impact factor: 4.965

View more
  60 in total

Review 1.  Drug interactions between herbal and prescription medicines.

Authors:  Elizabeth M Williamson
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Routine deprescribing of chronic medications to combat polypharmacy.

Authors:  Doron Garfinkel; Birkan Ilhan; Gulistan Bahat
Journal:  Ther Adv Drug Saf       Date:  2015-12

Review 3.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

4.  Possible interactions between dietary fibres and 5-aminosalicylic acid [corrected].

Authors:  Camilla Henriksen; Steen Hansen; Inge Nordgaard-Lassen; Jens Rikardt Anderson; Pia Madsen
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

5.  Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants.

Authors:  Arne Simon; Mette Besuden; Sandra Vezmar; Carola Hasan; Dagmar Lampe; Sigrid Kreutzberg; Axel Glasmacher; Udo Bode; Gudrun Fleischhack
Journal:  Support Care Cancer       Date:  2006-08-30       Impact factor: 3.603

6.  Food-drug interactions in the summary of product characteristics of proprietary medicinal products.

Authors:  M Teresa San Miguel; J Alfredo Martínez; Emilio Vargas
Journal:  Eur J Clin Pharmacol       Date:  2005-03-11       Impact factor: 2.953

7.  Predicting effect of food on extent of drug absorption based on physicochemical properties.

Authors:  Chong-Hui Gu; Hua Li; Jaquan Levons; Kimberley Lentz; Rajesh B Gandhi; Krishnaswamy Raghavan; Ronald L Smith
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

Review 8.  Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

9.  The effect of four different types of diet on the bioavailability of loracarbef.

Authors:  A T Bapujee; T Singh; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

10.  A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation.

Authors:  Marta Valle; Enrico Di Salle; Maria Gabriella Jannuzzo; Italo Poggesi; Maurizio Rocchetti; Riccardo Spinelli; Davide Verotta
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.